Skip to main content

Table 6 Multiple logistic regression derived odds ratios (and 95% Confidence Intervals) for the association between sample characteristics and immunization with all 3 newer vaccines (MenC, PCV7, Var)

From: Immunization coverage and predictive factors for complete and age-appropriate vaccination among preschoolers in Athens, Greece: a cross- sectional study

 

Complete immunization (n=731)

Age appropriate immunization at

12 months (n=731)

24 months (n=704)

 

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

Actual age

0.77 (0.65-0.91)

0.002

0.47 (0.35-0.64)

<0.001

0.45 (0.29-0.71)

0.001

Father’s nationality

Other

Reference

Greek

1.29 (0.88-1.90)

0.188

2.10(0.91-4.86)

0.082

2.95 (0.91-9.50)

0.071

Number of children

1

Reference

2

0.91 (0.64-1.31)

0.621

0.58 (0.31-1.09)

0.092

0.41 (0.19-0.90)

0.026

3+

0.77 (0.48-1.22)

0.265

0.42 (0.18-1.01)

0.053

0.27 (0.08-0.89)

0.031

Maternal education

≤12 years

Reference

>13 years

0.73 (0.53-1.02)

0.061

0.68 (0.38-1.22)

0.198

0.42 (0.19-0.94)

0.035

Use of multivalent vaccines

≤ 4-valent

Reference

5- or 6-valent

1.09 (0.78-1.50)

0.630

3.46 (1.51-7.92)

0.003

2.24 (0.88-5.68)

0.090

Impact of insurance reimbursement on the decision to vaccinate

No

Reference

Yes

0.95 (0.67-1.34)

0.764

1.22 (0.65-2.28)

0.538

1.28 (0.57-2.90)

0.551

Place of vaccination

Privately

Reference

Insurance clinic / Public health clinic

1.39 (0.95-2.03)

0.086

0.64 (0.32-1.30)

0.216

0.56 (0.23-1.36)

0.199

Type of insurance

IKA

Reference

Other

1.13 (0.77-1.66)

0.545

1.67 (0.84-3.34)

0.144

1.69 (0.70-4.11)

0.244

  1. Men C: conjugated meningococcal C vaccine; PCV7: conjugated pneumococcal 7-valent vaccine; Var: varicella vaccine.
  2. IKA: Social Security Institute.